The study looks at a condition called vasomotor symptoms, which are hot flashes and night sweats that can happen when sex hormones change in women and men. The medication being examined is an oral pill that contains the active ingredient elinzanetant, also known by its code name BAY 3427080, and it is provided in a soft gel capsule form.

The purpose of the study is to compare how much of the medication is absorbed into the bloodstream from different capsule formulations. Participants will take a single dose of each capsule type while fasting, meaning they will not eat for several hours before taking the medicine, and the study will follow a simple schedule where each dose is given at separate times.

Researchers will watch for any adverse events, which are side effects or unwanted reactions, and will record how often they occur and how severe they are, while also measuring how much of the drug reaches the blood to understand its bioavailability.